A paediatric extension extends the lifetime of a supplementary protection certificate (SPC) on a medicinal product by a further six months where an application for a marketing authorisation on the product includes the results of all studies performed and details of all information collected in compliance with an agreed paediatric investigation plan (PIP).

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.